U.S. FILLED & FINISHED | ≥99% COA-VERIFIED PURITY
LC-MS VERIFIED IDENTITY | INDEPENDENTLY TESTED

Heavy metals testing answers a question that neither purity nor endotoxin testing can: is the material free of toxic elemental contamination such as lead, arsenic, cadmium, and mercury. The standard method, ICP-MS, can detect these elements at extraordinarily low concentrations, and the modern framework governing acceptable limits, ICH Q3D, replaced a decades-old, far less precise test. This guide explains what heavy metals testing actually screens for and why it matters.
A peptide can be chemically pure, correctly identified, and free of bacterial contamination, and still carry toxic elemental impurities that none of those tests would ever catch. Heavy metals testing closes that gap, and the modern method behind it, ICP-MS, is precise enough to detect these elements at parts-per-billion concentrations.
In a pharmaceutical and research context, heavy metals refers to a set of toxic elemental contaminants, most critically lead, arsenic, cadmium, and mercury, that can enter a compound during raw material sourcing, synthesis, or manufacturing. These elements provide no therapeutic or research value and are known systemic toxicants capable of causing organ damage even at low levels of exposure [1]. Because they are elemental rather than organic, no amount of chemical purification aimed at peptide-related impurities will remove them; testing for them requires an entirely separate analytical method.
Research framing: This article explains laboratory quality testing methods. Compounds referenced are supplied by Badger Compounds for research use only and are not intended for human or veterinary use. Nothing here is medical advice.
Inductively coupled plasma mass spectrometry (ICP-MS) is the standard analytical method for identifying and quantifying elemental impurities. The sample is vaporized into a high-temperature argon plasma, which ionizes individual elements; those ions are then separated and measured by mass, producing an extremely sensitive, element-specific readout [2]. This is what allows ICP-MS to detect trace elements at concentrations far below what older, non-specific methods could resolve.
A neurotoxicant with no safe threshold of exposure, historically one of the most closely monitored contaminants in pharmaceuticals.
A known carcinogen linked to cardiovascular and neurological effects even at low chronic exposure.
Accumulates in the body over time and is associated with kidney and bone toxicity.
A potent neurotoxicant that can cross biological membranes and accumulate in tissue.
These four elements are consistently classified as the highest-priority toxic metals of public health significance, which is why they anchor every heavy metals testing panel [1].
For nearly a century, the pharmaceutical industry relied on a nonspecific colorimetric test that measured total “heavy metals” as a single lumped value without identifying which elements were actually present. That approach has been replaced by ICH Q3D, the internationally harmonized guideline that classifies elemental impurities by toxicity and likelihood of occurrence and establishes permitted daily exposure limits for each one [3]. Modern ICP-MS methods were adopted specifically because they can resolve individual elements, including arsenic and lead at very low concentrations, in a way the older test never could [3].
A complete Certificate of Analysis reports heavy metals as its own distinct panel, separate from purity, identity, and endotoxin results, because it answers a question none of the others do. For how this fits into the full picture of a COA, see our guide on how to read a Certificate of Analysis, and for the complementary contamination check, see our overview of endotoxin testing and the LAL assay.
Every compound in our catalog is independently tested per batch across a full panel, with publicly viewable COAs. For qualified laboratory research use only.
Browse the CatalogBadger Compounds Research Access
This catalog is reserved for qualified research use. Confirm below to continue.
Please confirm both statements and select a research type.